SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
Nicholas Hartog, William E. Faber, Austin Frisch, Jacob Bauss, Caleb Bupp, Surender Rajasekaran, Jeremy W. Prokop
Abstract
: A growing level of support suggests the need for stronger integration of biomarkers and precision medicine to guide treatment strategies of severe COVID-19, where each patient has unique outcomes and thus require guided treatment.
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)GenomeRNA2019-20 coronavirus outbreakVirologyMedicineBiologyComputational biologyBioinformaticsGeneticsDiseaseGeneInfectious disease (medical specialty)Internal medicineOutbreakCOVID-19 Clinical Research StudiesInflammasome and immune disordersLong-Term Effects of COVID-19